TV Ad Spots on Air Now!

Filter by:
All Sectors
All Companies
Clear all filters
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HHIC - Harvest ETFs: Built for Income, Designed for Canada
ETFs
January 12, 2026

HHIC - Harvest ETFs: Built for Income, Designed for Canada

Harvest ETFs’ HHIC offers exposure to Canada’s leading businesses with a focus on high monthly income and consistent performance.

ETFs
No items found.
Harvest ETFs: Unlock Consistent Income with the Diversified High Income Shares ETF
ETFs
January 12, 2026

Harvest ETFs: Unlock Consistent Income with the Diversified High Income Shares ETF - HHIS

Harvest ETFs launches the Diversified High Income Shares ETF, offering investors a single solution for stable, high monthly income through a basket of top-performing income-generating ETFs.

ETFs
Harvest
Harvest ETFs
Harvest ETF'S
ETF
ETFs
Titan Mining: Strengthening America’s Critical Mineral Supply Chain
Metals & Mining
January 8, 2026

Titan Mining: Strengthening America’s Critical Mineral Supply Chain

As the U.S. continues to import 100% of its natural graphite—a vital component in energy storage, defense, and advanced manufacturing—Titan Mining is rising to the challenge.

Metals & Mining
Titan Mining
mining stocks
critical metals
Critical Minerals
TSX: TI
HIVE Digital Technologies: Building the Future with Bitcoin and AI
Tech
January 6, 2026

HIVE Digital Technologies: Building the Future with Bitcoin and AI

HIVE Digital Technologies (TSX.V: HIVE, NASDAQ: HIVE) isn’t just mining Bitcoin—it’s powering the next era of high-performance computing. With a strong focus on sustainability and AI infrastructure, HIVE is executing on two transformative trends at once.

Tech
HIVE
HIVE Digital Technologies
technology stocks to buy
cryptomining
bitcoin
BriaCell: Advancing Toward Approval with Late-Stage Breast Cancer Immunotherapy
December 18, 2025

BriaCell: Advancing Toward Approval with Late-Stage Breast Cancer Immunotherapy

BriaCell Therapeutics is in the final stages of clinical testing for its innovative immunotherapy in metastatic breast cancer, offering a new treatment path for patients with limited options.

BriaCell
Investing
stocks
Health
No items found.